Negative inotropic effect of leukotrienes: leukotrienes C4 and D4 inhibit calcium-dependent contractile responses in potassium-depolarized guinea-pig myocardium.
The effects of the sulfidopeptide leukotrienes (LTs) on the contractile response of electrically paced guinea-pig right ventricular papillary muscles in vitro were studied. LTs caused a concentration-dependent (1 nM-20 microM) negative inotropic effect; the order of relative potency was LTC4 greater than or equal to LTD4 greater than LTE4. A maximal 30% decrease in contractility occurred with 1 microM LTC4. The LT-induced decrease in contractile force was not mediated by cyclooxygenase products of the arachidonic acid cascade, as it was not influenced by indomethacin (14 microM). On the other hand, the slow-reacting substance-antagonist compound FPL 55712 (480 nM) caused a marked shift to the right of the LTC4 concentration-response curve. Because the negative inotropic effect of LTD4 was attenuated by increasing [Ca++]o, we next assessed the negative inotropic effect of LTs under conditions in which myocardial contractility depends solely on the slow inward Ca++ current. As a model, we used the isoproterenol- or histamine-induced restoration of contractile response in papillary muscles rendered inexcitable by 22 mMK+. LTC4 (16-480 nM) and LTD4 (20-600nM) inhibited isoproterenol- and histamine-induced restoration of contractility in a dose-dependent manner; a maximal 90% inhibition occurred with 0.48 microM LTC4. This effect of LTs was reversed by an elevation in [Ca++]o from 1.8 to 5.4 mM and prevented by FPL 55712 (480 nM). In muscles maintained at 5.4 mM [K+]o, LTC4 (160 and 480 nM) and LTD4 (1 microM) shifted the force-frequency curve (0.1-2 Hz) downwards in a parallel fashion; a similar alteration was obtained by lowering [Ca++]o to 1 mM.
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002867:Chromones / Q000494:pharmacology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D017999:Leukotriene E4; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D011188:Potassium / Q000494:pharmacology*; D013189:SRS-A / Q000031:analogs & derivatives / Q000494:pharmacology*
D002867:Chromones; D013189:SRS-A; D017999:Leukotriene E4; D006632:Histamine; C006312:FPL 55712; D007545:Isoproterenol; D011188:Potassium; D002118:Calcium; D007213:Indomethacin